Total amount raised
$165 Million
Latest funding date
1/1/2025
Location
Suki has successfully raised funding over 7 rounds, with the latest being a "Venture - Series Unknown" round. The company is backed by 18 investors, including notable names like Zoom Ventures and March Capital.
Keep reading to explore the intricacies of Suki's fundraising journey and the investors backing this innovative platform.
What Is Suki?
Suki is a healthcare technology company based in Redwood City, California, specializing in AI-driven solutions to streamline healthcare documentation processes. Founded in an unspecified year, the company operates within the industries of Artificial Intelligence, Health Care, Machine Learning, Natural Language Processing, and Software.
With a workforce of 251-500 employees, Suki's main product, Ambient Clinical Intelligence, aims to enhance patient care by providing essential AI infrastructure. The platform offers features like Ambient Documentation, Assisted Revenue Cycle, and Clinical Reasoning, making it a comprehensive solution for clinicians and healthtech partners.
How Much Funding Has Suki Raised?
- Seed Round
- Amount Raised: USD 5,000,000
- Date: March 2016
- Lead Investors: First Round Capital, Venrock
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop the initial AI-driven healthcare documentation platform.
- Seed Round
- Amount Raised: Not publicly disclosed
- Date: January 2017
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To continue product development and early market testing.
- Series A
- Amount Raised: USD 15,000,000
- Date: May 2018
- Lead Investors: Venrock
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale the platform and expand the team.
- Series B
- Amount Raised: USD 20,000,000
- Date: March 2020
- Lead Investors: Flare Capital Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To enhance product features and increase market penetration.
- Series C
- Amount Raised: USD 55,000,000
- Date: December 2021
- Lead Investors: March Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand partnerships and improve AI capabilities.
- Series D
- Amount Raised: USD 70,000,000
- Date: October 2024
- Lead Investors: Hedosophia
- Valuation at Round: Approximately USD 500,000,000
- Motivation Behind the Round: To accelerate product development, add more features, and build tools to manage multiple AI models.
- Series Unknown
- Amount Raised: Not publicly disclosed
- Date: January 2025
- Lead Investors: Zoom Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further enhance AI infrastructure and expand market reach.
Total Amount Raised: USD 165,000,000. Current Valuation: Approximately USD 500,000,000.
Key Investors
- Zoom Ventures
- Details: Zoom Ventures is a venture capital firm known for its strategic investments in technology and innovation. The firm has been a lead investor in multiple funding rounds for Suki.
- Investment Focus Areas: Technology, innovation, healthcare.
- Notable Investments: Not publicly disclosed.
- March Capital
- Details: March Capital is a venture capital firm that invests in technology and growth-stage companies. The firm participated in Suki's Series D funding round.
- Investment Focus Areas: Technology, growth-stage companies, innovation.
- Notable Investments: CrowdStrike, ASAPP, ThoughtSpot.
- Hedosophia
- Details: Hedosophia is a London-based tech investment firm known for its focus on technology and innovation. The firm led Suki's Series D funding round.
- Investment Focus Areas: Technology, innovation, growth-stage companies.
- Notable Investments: Not publicly disclosed.
- Venrock
- Details: Venrock is a venture capital firm with a long history of investing in technology and healthcare startups. The firm has been involved with Suki since the seed stage.
- Investment Focus Areas: Healthcare, technology, energy.
- Notable Investments: Apple, Intel, Gilead Sciences.
- Flare Capital
- Details: Flare Capital is a venture capital firm specializing in healthcare technology investments. The firm participated in Suki's Series D funding round.
- Investment Focus Areas: Healthcare technology, innovation, digital health.
- Notable Investments: Not publicly disclosed.
What's Next for Suki?
Suki stands at the cusp of significant opportunities, driven by the growing demand for AI solutions in healthcare. With partnerships spanning over 300 health systems and deep integrations with major EHR systems, the company is well-positioned to capitalize on the expanding market for AI-driven administrative tools. The recent $70 million Series D funding will accelerate product development and expand the capabilities of Suki Assistant and Suki Platform, enhancing their utility for clinicians.
Future fundraising opportunities appear promising as Suki continues to demonstrate its impact and scalability. The healthcare AI market's rapid growth suggests that additional funding rounds could be on the horizon, enabling Suki to further expand its product offerings and market reach. However, the company faces challenges such as intense competition from established players like Microsoft-owned Nuance and the need to maintain seamless EHR integrations.
Use Clay to Get Funding Data
Sales professionals, leverage Clay's platform to access comprehensive fundraising data on companies like Suki and gather other critical business insights. Sign up for free to start unlocking valuable information today.
